Mediolanum International Funds Ltd Boosts Stock Position in GE HealthCare Technologies Inc. $GEHC

Mediolanum International Funds Ltd lifted its holdings in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 32.0% during the 3rd quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 328,156 shares of the company’s stock after acquiring an additional 79,471 shares during the period. Mediolanum International Funds Ltd owned 0.07% of GE HealthCare Technologies worth $23,985,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also recently bought and sold shares of the stock. True North Advisors LLC grew its holdings in shares of GE HealthCare Technologies by 2.0% during the third quarter. True North Advisors LLC now owns 6,987 shares of the company’s stock worth $525,000 after purchasing an additional 139 shares during the last quarter. Klingman & Associates LLC lifted its stake in shares of GE HealthCare Technologies by 4.0% in the 3rd quarter. Klingman & Associates LLC now owns 3,634 shares of the company’s stock worth $273,000 after acquiring an additional 139 shares during the period. Golden State Wealth Management LLC lifted its position in GE HealthCare Technologies by 7.4% in the second quarter. Golden State Wealth Management LLC now owns 2,138 shares of the company’s stock valued at $158,000 after purchasing an additional 148 shares during the period. Exchange Traded Concepts LLC lifted its holdings in shares of GE HealthCare Technologies by 1.3% in the 3rd quarter. Exchange Traded Concepts LLC now owns 11,490 shares of the company’s stock valued at $863,000 after buying an additional 150 shares during the period. Finally, Modera Wealth Management LLC lifted its holdings in GE HealthCare Technologies by 3.5% in the second quarter. Modera Wealth Management LLC now owns 4,500 shares of the company’s stock valued at $333,000 after acquiring an additional 152 shares during the period. 82.06% of the stock is currently owned by institutional investors and hedge funds.

GE HealthCare Technologies Stock Up 0.2%

Shares of NASDAQ GEHC opened at $78.97 on Friday. The firm has a market cap of $35.97 billion, a P/E ratio of 16.32, a price-to-earnings-growth ratio of 2.38 and a beta of 1.08. The company has a debt-to-equity ratio of 0.83, a quick ratio of 0.95 and a current ratio of 1.18. GE HealthCare Technologies Inc. has a 1 year low of $57.65 and a 1 year high of $94.80. The firm’s 50 day moving average price is $82.63 and its 200 day moving average price is $77.37.

GE HealthCare Technologies (NASDAQ:GEHC) last issued its quarterly earnings results on Wednesday, October 29th. The company reported $1.07 earnings per share for the quarter, topping analysts’ consensus estimates of $1.05 by $0.02. GE HealthCare Technologies had a return on equity of 22.52% and a net margin of 10.94%.The company had revenue of $5.14 billion for the quarter, compared to analyst estimates of $5.07 billion. During the same quarter in the prior year, the company posted $1.14 EPS. The business’s revenue for the quarter was up 5.8% compared to the same quarter last year. As a group, sell-side analysts anticipate that GE HealthCare Technologies Inc. will post 4.68 earnings per share for the current year.

GE HealthCare Technologies Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, February 13th. Investors of record on Friday, January 9th will be paid a $0.035 dividend. This represents a $0.14 annualized dividend and a yield of 0.2%. The ex-dividend date is Friday, January 9th. GE HealthCare Technologies’s dividend payout ratio is presently 2.89%.

Analyst Upgrades and Downgrades

A number of equities research analysts have recently issued reports on the stock. Morgan Stanley lifted their price target on shares of GE HealthCare Technologies from $74.00 to $80.00 and gave the company an “equal weight” rating in a research report on Thursday, October 30th. Evercore ISI reissued an “outperform” rating and set a $95.00 price objective on shares of GE HealthCare Technologies in a research note on Monday, January 5th. Stifel Nicolaus lifted their price objective on GE HealthCare Technologies from $90.00 to $95.00 and gave the stock a “buy” rating in a research report on Wednesday, January 7th. Wells Fargo & Company lowered their target price on GE HealthCare Technologies from $89.00 to $87.00 and set an “overweight” rating on the stock in a report on Thursday, October 30th. Finally, Citigroup boosted their price target on GE HealthCare Technologies from $83.00 to $88.00 and gave the stock a “neutral” rating in a report on Thursday, December 11th. Seven equities research analysts have rated the stock with a Buy rating, six have given a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Hold” and an average price target of $90.33.

GE HealthCare Technologies Profile

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.